70 Followers on Owler

iOnctura

Read more
Catherine Pickering's photo - Co-Founder & CEO of iOnctura

Co-Founder & CEO

Catherine Pickering

CEO Approval Rating

87/100

Founded:

2017

Status:

PrivateIndependent Company

Est. Annual Revenue
$1.2M
Agree?
Est. Employees
10
Agree?

IONCTURA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

iOnctura's company profile
Catherine Pickering's photo - Co-Founder & CEO of iOnctura

Catherine Pickering

Co-Founder & CEO

87/100
10
$22.4M
$1.2M
View Profile
1
iOnctura's Competitor - T3 Pharmaceuticals logo
Simon J. Ittig's photo - CEO of T3 Pharmaceuticals

Simon J. Ittig

CEO

89/100
21
$39.1M
$2.5M
View Profile
2
iOnctura's Competitor - Anaveon logo
Andreas Katopodis's photo - Co-Founder & CEO of Anaveon

Andreas Katopodis

Co-Founder & CEO

90/100
3
$35M
$1.5M
View Profile
3
iOnctura's Competitor - TargImmune Therapeutics logo
Peter  L. Braun's photo - CEO of TargImmune Therapeutics

Peter L. Braun

CEO

90/100
35
$19.2M
$2.1M
View Profile
4
iOnctura's Competitor - NexImmune logo
Scott P. Carmer's photo - CEO of NexImmune

Scott P. Carmer

CEO

85/100
44
$162.8M
View Profile
5
iOnctura's Competitor - bluebird bio logo
Nick Leschly's photo - President & CEO of bluebird bio

Nick Leschly

President & CEO

74/100
764
$526.4M
$50.2M
View Profile
6
iOnctura's Competitor - Kite Pharma logo
Christi L. Shaw's photo - CEO of Kite Pharma

Christi L. Shaw

CEO

81/100
2,000
$634.9M
$45M
View Profile
7
iOnctura's Competitor - Nouscom logo
Marina Udier's photo - CEO of Nouscom

Marina Udier

CEO

90/100
25
$62.4M
$3M
View Profile
8
iOnctura's Competitor - Amphivena logo
Curtis L. Ruegg's photo - President & CEO of Amphivena

Curtis L. Ruegg

President & CEO

90/100
20
$127.2M
$3.7M
View Profile
9
iOnctura's Competitor - Virometix logo
Anna Sumeray's photo - CEO of Virometix

Anna Sumeray

CEO

89/100
40
$14.3M
$10M
View Profile
10
iOnctura's Competitor - Meditope logo
Stephanie Hsieh's photo - President & CEO of Meditope

Stephanie Hsieh

President & CEO

82/100
30
$7.3M
$9.8M
View Profile
11
iOnctura's Competitor - TOLREMO logo
Stefanie Fluckiger-Mangual's photo - Co-Founder & CEO of TOLREMO

Stefanie Fluckiger-Mangual

Co-Founder & CEO

89/100
15
$16.8M
$3M
View Profile
12
iOnctura's Competitor - Ziopharm logo
Kevin S. Boyle Sr.'s photo - CEO of Ziopharm

Kevin S. Boyle Sr.

CEO

83/100
48
$368.8M
$ < 1M
View Profile

Missing a competitor? Contribute!

T3 Pharmaceuticals is a top competitor of iOnctura. T3 Pharmaceuticals was founded in 2015, and is headquartered in Basel, Basel-Country. Like iOnctura, T3 Pharmaceuticals also competes in the Biotechnology field. T3 Pharmaceuticals generates $1.3M more revenue vs. iOnctura.

Anaveon is seen as one of iOnctura's top competitors. Anaveon is headquartered in Basel, Basel-City, and was founded in 2017. Like iOnctura, Anaveon also operates in the Biotechnology field. Anaveon generates 125% the revenue of iOnctura.

TargImmune Therapeutics has been one of iOnctura's top competitors. TargImmune Therapeutics's headquarters is in Basel, Basel-City, and was founded in 2016. Like iOnctura, TargImmune Therapeutics also works within the Biotechnology industry. TargImmune Therapeutics generates 175% of iOnctura's revenue.

iOnctura Acquisitions

No recent acquisitions found related to iOnctura

iOnctura Funding History

Since iOnctura was founded in 2017, it has participated in 3 rounds of funding. In total iOnctura has raised $22.4M. iOnctura's last funding round was on Jul 2020 for a total of $5.8M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Jul 2020
$5.8M
Series A
Jan 2020
$16.6M
Seed
Jun 2017
--

Since iOnctura was founded in 2017, it has participated in 3 rounds of funding. In total iOnctura has raised $22.4M. iOnctura's last funding round was on Jul 2020 for a total of $5.8M

iOnctura Investments

No recent investments found related to iOnctura

iOnctura News

August 13, 2020Pharamceutical Technology

iOnctura raises 20.1m in a Series A round

Switzerland-headquartered oncology biotech iOnctura has closed a €20.1m Series A round led by existin... See more »
July 15, 2020News Break

3B Future Health Fund announces new investment in iOnctura | News Break

3B Future Health Fund announces new investment in iOnctura. MONACO, PRINCIPALITY OF MONACO, July 14, ... See more »
July 14, 2020FinSMEs

iOnctura Raises Additional 5.1M; Series A to 20.1M

iOnctura SA, a Geneva, Switzerland-based clinical...... See more »
February 27, 2020startupticker

iOnctura announces start of clinical trial

iOnctura develops a pipeline of next generation molecules targeting cancer and fibrosis. The first pa... See more »
January 24, 2020startupticker ch

Geneva-based biopharma startup raises €15 million

Founded in 2017 in Geneva, iOnctura is developing a pipeline of next-generation molecules targeting c... See more »
January 23, 2020FierceBiotech

Merck KGaA spinout iOnctura raises cash for cancer trials

Merck KGaA spinout iOnctura has raised a €15 million ($17 million) series A round to support an early... See more »
March 18, 2019Manufacturing Chemist

Former Eli Lilly executive joins iOnctura

Michael Lahn has joined the late-stage preclinical immuno-oncology company as the new Chief Medical O... See more »

Social Media

iOnctura Headquarters

Avenue Sécheron 15 Campus Biotech Innovation Park, Building F2

Geneva, Geneva1202

Driving Directions »

Trending Companies

iOnctura Summary

ABOUT

Overview

iOnctura is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer. iOnctura was founded in 2017. iOnctura's headquarters is located in Geneva, Geneva, CH 1202. It has raised 22.4M in 3 rounds. The ...

CEO

iOnctura's Co-Founder & CEO, Catherine Pickering, currently has an approval rating of 87%. iOnctura's primary competitors are T3 Pharmaceuticals, Anaveon & TargImmune Therapeutics.

Frequently Asked Questions about iOnctura

  1. When was iOnctura founded?

    iOnctura was founded in 2017
  2. Who is iOnctura's CEO?

    iOnctura's CEO is Catherine Pickering
  3. How much revenue does iOnctura generate?

    iOnctura generates $1.2M in revenue
  4. How much funding does iOnctura have?

    iOnctura has historically raised $22.4M in funding
  1. Where is iOnctura's headquarters?

    iOnctura's headquarters is in Geneva Geneva, CH
  2. How many employees does iOnctura have?

    iOnctura has 10 employees
  3. What sector does iOnctura operate in?

    iOnctura is in Biotechnology, Pharmaceuticals
  4. Who are iOnctura's competitors?

    iOnctura's top competitors are T3 Pharmaceuticals, Anaveon, TargImmune Therapeutics